- cafead Mar 12, 2019 at 10:22: AM
via A Bayer heart failure project gets a high-profile unveiling, while Amarin and Esperion get a chance to reinforce their lipid-lowering candidates.
article source
article source
-
Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page
ACC 2019 preview – Bayer hopes for heart failure panache
- Thread starter cafead
- Start date
<
Similar threads